Business
CBDUAL BIOTECHNOLOGY CORP announces open house to celebrate launch of our new clinical research trials center
CBDUAL BIOTECHNOLOGY CORP announces open house to celebrate launch of our new clinical research trials center.

About this update from Thc Farmaceuticals, Inc
[{"type":"text","content":"For Immediate ReleaseApril 15 2019CBDual Biotechnology Corp announced today that in partnership with 1000 Smiles Dental which is located in Newbury Park, CA that its grand opening ceremony will be held on Tuesday April 16th at 4 pm PST. The ribbon cutting will be held with the leadership and members of the Thousand Oaks Chamber of Commerce.Our state-of- the-art clinical trials facility is an efficiently designed suite featuring attractive finishes, plenty of outside light and modern technology. It is located in the Regency Medical plaza, a well-known and established medical office complex in Ventura County, featuring an on-site compounding pharmacy and located in close proximity to Los Robles Regional Medical Center.CBDual Biotechnology Corp partnered up with 1000 Smiles Dental to create the first CBD based dental hygiene product line and conduct clinical trials in the first research center of its kind. The clinical trials will begin its pre-clinical phase within the next few months.“Cbdual’s new clinical trial facility holds the promise to discover new ways cannabidiol (CBD) can be implemented in medical and dental treatments and serve to be an alternative treatment option for oral health and wellbeing,” Dr. Greg Rubin stated, our Founder and CEO. “As clinical research into the therapeutic value of cannabinoids has proliferated recently, researchers understanding of cannabis many natural compounds remarkable capacity to improve and treat diseases and conditions , including potentially gum disease, has increased.With the emerging indications and abundance of clinical research indicating the effectiveness of CBD (cannabidiol) in medicine, such as the antibacterial and anti-inflammatory and several other features being the most well-known properties, these happen to be the most needed qualities in dentistry. Clinical trials will be conducted on volunteers. Early registration to participate in clinical trials will begin soon. ” We’re aware of the growing public interest in cannabis and cannabis-derived products, including cannabidiol (CBD).” said FDA Commissioner Scott Gottlieb, M.D. in his recent statement.CBDual Biotechnology will apply for FDA approval for its product line upon completion of a series of clinical trials.The Surgeon General’s Report on health was published few years a...